Identification of cisplatin-resistant factor by integration of transcriptomic and proteomic data using head and neck carcinoma cell lines

Cisplatin is an important drug for the treatment of head and neck squamous cell carcinoma (HNSCC). Determining chemoresistant factors prior to treatment will lead to great benefits for clinicians and patients. Here, we evaluated chemoresistant factors by integrating proteomic and transcriptomic data...

Descripción completa

Detalles Bibliográficos
Autores principales: Inukai, Daisuke, Nishimura, Kunihiro, Okamoto, Hiroki, Sano, Rui, Ueda, Hiromi, Ota, Akinobu, Karnan, Sivasundaram, Hosokawa, Yoshitaka, Yoshikawa, Kazuhiro, Suzuki, Susumu, Ueda, Ryuzo, Murotani, Kenta, Bradford, Carol R., Ogawa, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nagoya University 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548249/
https://www.ncbi.nlm.nih.gov/pubmed/33132436
http://dx.doi.org/10.18999/nagjms.82.3.519

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7548249/
https://www.ncbi.nlm.nih.gov/pubmed/33132436
http://dx.doi.org/10.18999/nagjms.82.3.519

Ejemplares similares